<DOC>
	<DOCNO>NCT01303107</DOCNO>
	<brief_summary>The purpose study determine mixture enantiomer bupivacaine ( bupivacaine S75 : R25 ) do represent inferiority efficacy safety compare racemic mixture enantiomer bupivacaine ( bupivacaine S50 : R50 ) .</brief_summary>
	<brief_title>Comparative Mixture Non-racemic Racemic Enantiomers Bupivacaine Cesarean</brief_title>
	<detailed_description>The enantiomeric mixture bupivacaine S75 : R25 ( 75 % levobupivacaine 25 % bupivacaine ) develop safety regional anesthetic substitution racemic bupivacaine ( S50 : R50 ) .</detailed_description>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>parturients term ASA ( American Society Anesthesiologists ) I ASA II elective cesarean section low risk labor prenatal followup patient consent relative absolute contraindication spinal anesthesia history hypersensitivity local anesthetic use opioids labor labor last 12 hour less 1 hour complication pregnancy placenta previa , preeclampsia eclampsia ; maternalfetal malnutrition ; important accident pregnancy . spinal lesion , peripheral neuropathy neurologic disorder lead change sensitivity and/or motricity decompensated diabetes hypertension history alcohol and/or drug abuse cardiopathy , especially myocardiopathies valvulopathies ; important cognitive change change safety exams twin pregnancy ; sign intrauterine distress , abnormality fetal vitality , prematurity</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>